
Flexible Pricing Policy in Emerging and Developing Countries
In addition to the patient contribution through innovative new drug development and sales, ˶ has established a core strategy consisted of affordable pricing, provision of disease solutions, public-private partnerships and local partnerships, to contribute to improving access to medicines in emerging and developing countries.
Flexible Pricing Policy in Emerging and Developing Countries
Approval Status of Global Products
˶ strives to bring products to many patients who need them all over the world. Please visit to see the approval status of ˶ global products in each country and region.
Approval Status of Global Products